Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention

Published:2015-01 Issue:1 Volume:8 Page:214-220
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Clemmensen Peter,Wiberg Sebastian,van't Hof Arnoud,Deliargyris Efthymios N.,Coste Pierre,ten Berg Jurrien,Cavallini Claudio,Hamon Martial,Dudek Dariusz,Zeymer Uwe,Tabone Xavier,Kristensen Steen D.,Bernstein Debra,Anthopoulos Prodromos,Prats Jayne,Steg Philippe Gabriel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction;Dangas;Circulation,2011

2. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents;Kukreja;J Am Coll Cardiol Intv,2009

3. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications;Luscher;Circulation,2007

4. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study;Nakano;J Am Coll Cardiol,2014

5. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes;Dangas;J Am Coll Cardiol Intv,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis;American Journal of Cardiovascular Drugs;2024-04-29

2. Reduced-dose without the post-procedure infusion of bivalirudin in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention;2023-11-30

3. Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions;Journal of Clinical Medicine;2023-11-28

4. Bivalirudin in acute coronary syndromes;Expert Review of Cardiovascular Therapy;2023-11-07

5. Bivalirudin versus heparin in STEMI after BRIGHT-4 trial: an updated meta-analysis;Coronary Artery Disease;2023-09-20